Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Sci Signal ; 4(187): er3, 2011 Aug 23.
Article in English | MEDLINE | ID: mdl-21972468

ABSTRACT

The skin is the largest sensory organ of the body. It is innervated by a diverse array of primary sensory neurons, including a heterogeneous subset of unmyelinated afferents called C fibers. C fibers, sometimes classified as nociceptors, can detect various painful stimuli, including temperature extremes. However, it is increasingly evident that these afferents respond to various pruritic stimuli and transmit information to the brain that is perceived as itch; this can subsequently drive scratching behavior. Although itch and pain are distinct sensations, they are closely related and can, under certain circumstances, antagonize each other. However, it is not clear precisely when, where, and how the processes generating these two sensations originate and how they are dissociated. Clues have come from the analysis of the activities of specific ligands and their receptors. New data indicate that specific pruritic ligands carrying both itch and pain information are selectively recognized by different G protein­coupled receptors (GPCRs), and this information may be transduced through different intracellular circuits in the same neuron. These findings raise questions about the intracellular mechanisms that preprocess and perhaps encode GPCR-mediated signals.

2.
Sci Signal ; 4(185): pe38, 2011 Aug 02.
Article in English | MEDLINE | ID: mdl-21868356

ABSTRACT

The skin is the largest sensory organ of the body. It is innervated by a diverse array of primary sensory neurons, including a heterogeneous subset of unmyelinated afferents called C fibers. C fibers, sometimes classified as nociceptors, can detect various painful stimuli, including temperature extremes. However, it is increasingly evident that these afferents respond to various pruritic stimuli and transmit information to the brain that is perceived as itch; this can subsequently drive scratching behavior. Although itch and pain are distinct sensations, they are closely related and can, under certain circumstances, antagonize each other. However, it is not clear precisely when, where, and how the processes generating these two sensations originate and how they are dissociated. Clues have come from the analysis of the activities of specific ligands and their receptors. New data indicate that specific pruritic ligands carrying both itch and pain information are selectively recognized by different G protein-coupled receptors (GPCRs), and this information may be transduced through different intracellular circuits in the same neuron. These findings raise questions about the intracellular mechanisms that preprocess and perhaps encode GPCR-mediated signals.


Subject(s)
Nerve Fibers, Unmyelinated/metabolism , Pain/metabolism , Pruritus/metabolism , Receptors, G-Protein-Coupled/metabolism , Signal Transduction , Animals , Humans
3.
Proc Natl Acad Sci U S A ; 108(8): 3371-6, 2011 Feb 22.
Article in English | MEDLINE | ID: mdl-21300878

ABSTRACT

Despite its clinical importance, the mechanisms that mediate or generate itch are poorly defined. The identification of pruritic compounds offers insight into understanding the molecular and cellular basis of itch. Imiquimod (IQ) is an agonist of Toll-like receptor 7 (TLR7) used to treat various infectious skin diseases such as genital warts, keratosis, and basal cell carcinoma. Itch is reportedly one of the major side effects developed during IQ treatments. We found that IQ acts as a potent itch-evoking compound (pruritogen) in mice via direct excitation of sensory neurons. Combined studies of scratching behavior, patch-clamp recording, and Ca(2+) response revealed the existence of a unique intracellular mechanism, which is independent of TLR7 as well as different from the mechanisms exploited by other well-characterized pruritogens. Nevertheless, as for other pruritogens, IQ requires the presence of transient receptor potential vanilloid 1 (TRPV1)-expressing neurons for itch-associated responses. Our data provide evidence supporting the hypothesis that there is a specific subset of TRPV1-expressing neurons that is equipped with diverse intracellular mechanisms that respond to histamine, chloroquine, and IQ.


Subject(s)
Aminoquinolines/pharmacology , Neurons/chemistry , Pruritus/metabolism , TRPV Cation Channels/analysis , Aminoquinolines/adverse effects , Animals , Chloroquine/pharmacology , Histamine/pharmacology , Imiquimod , Interferon Inducers , Mice , Pruritus/chemically induced , Pruritus/etiology
4.
Proc Natl Acad Sci U S A ; 107(33): 14851-6, 2010 Aug 17.
Article in English | MEDLINE | ID: mdl-20679217

ABSTRACT

Increasing evidence supports the notion that spinal cord microglia activation plays a causal role in the development of neuropathic pain after peripheral nerve injury; yet the mechanisms for microglia activation remain elusive. Here, we provide evidence that NADPH oxidase 2 (Nox2)-derived ROS production plays a critical role in nerve injury-induced spinal cord microglia activation and subsequent pain hypersensitivity. Nox2 expression was induced in dorsal horn microglia immediately after L5 spinal nerve transection (SNT). Studies using Nox2-deficient mice show that Nox2 is required for SNT-induced ROS generation, microglia activation, and proinflammatory cytokine expression in the spinal cord. SNT-induced mechanical allodynia and thermal hyperalgesia were similarly attenuated in Nox2-deficient mice. In addition, reducing microglial ROS level via intrathecal sulforaphane administration attenuated mechanical allodynia and thermal hyperalgesia in SNT-injured mice. Sulforaphane also inhibited SNT-induced proinflammatory gene expression in microglia, and studies using primary microglia indicate that ROS generation is required for proinflammatory gene expression in microglia. These studies delineate a pathway involving nerve damage leading to microglial Nox2-generated ROS, resulting in the expression of proinflammatory cytokines that are involved in the initiation of neuropathic pain.


Subject(s)
Membrane Glycoproteins/metabolism , Microglia/metabolism , NADPH Oxidases/metabolism , Neuralgia/physiopathology , Reactive Oxygen Species/metabolism , Animals , Blotting, Western , Cells, Cultured , Gene Expression , Hyperalgesia/physiopathology , Hyperalgesia/prevention & control , Immunohistochemistry , Injections, Spinal , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Isothiocyanates , Male , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Microglia/cytology , NADPH Oxidase 2 , NADPH Oxidases/genetics , Neuralgia/etiology , Neuralgia/prevention & control , Pain Measurement/methods , Peripheral Nerve Injuries , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Spinal Cord/metabolism , Sulfoxides , Thiocyanates/administration & dosage , Thiocyanates/pharmacology , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
5.
Proc Natl Acad Sci U S A ; 106(27): 11330-5, 2009 Jul 07.
Article in English | MEDLINE | ID: mdl-19564617

ABSTRACT

The mechanisms that generate itch are poorly understood at both the molecular and cellular levels despite its clinical importance. To explore the peripheral neuronal mechanisms underlying itch, we assessed the behavioral responses (scratching) produced by s.c. injection of various pruritogens in PLCbeta3- or TRPV1-deficient mice. We provide evidence that at least 3 different molecular pathways contribute to the transduction of itch responses to different pruritogens: 1) histamine requires the function of both PLCbeta3 and the TRPV1 channel; 2) serotonin, or a selective agonist, alpha-methyl-serotonin (alpha-Me-5-HT), requires the presence of PLCbeta3 but not TRPV1, and 3) endothelin-1 (ET-1) does not require either PLCbeta3 or TRPV1. To determine whether the activity of these molecules is represented in a particular subpopulation of sensory neurons, we examined the behavioral consequences of selectively eliminating 2 nonoverlapping subsets of nociceptors. The genetic ablation of MrgprD(+) neurons that represent approximately 90% of cutaneous nonpeptidergic neurons did not affect the scratching responses to a number of pruritogens. In contrast, chemical ablation of the central branch of TRPV1(+) nociceptors led to a significant behavioral deficit for pruritogens, including alpha-Me-5-HT and ET-1, that is, the TRPV1-expressing nociceptor was required, whether or not TRPV1 itself was essential. Thus, TRPV1 neurons are equipped with multiple signaling mechanisms that respond to different pruritogens. Some of these require TRPV1 function; others use alternate signal transduction pathways.


Subject(s)
Behavior, Animal , Neurons, Afferent/metabolism , Pruritus/metabolism , TRPV Cation Channels/metabolism , Animals , Behavior, Animal/drug effects , Endothelin-1/administration & dosage , Endothelin-1/pharmacology , Injections , Mice , Mice, Inbred C57BL , Models, Biological , Mutation/genetics , Neurons, Afferent/drug effects , Neurons, Afferent/enzymology , Nociceptors/metabolism , Pain/metabolism , Phospholipase C beta/deficiency , Phospholipase C beta/metabolism , Physical Stimulation , Posterior Horn Cells/drug effects , Posterior Horn Cells/metabolism , Posterior Horn Cells/pathology , Proto-Oncogene Proteins c-fos/metabolism , Serotonin/administration & dosage , Serotonin/analogs & derivatives , Serotonin/pharmacology , Temperature
6.
Chembiochem ; 8(13): 1527-39, 2007 Sep 03.
Article in English | MEDLINE | ID: mdl-17647204

ABSTRACT

We report the 3D structure predicted for the mouse MrgC11 (mMrgC11) receptor by using the MembStruk computational protocol, and the predicted binding site for the F-M-R-F-NH(2) neuropeptide together with four singly chirally modified ligands. We predicted that the R-F-NH(2) part of the tetrapeptide sticks down into the protein between the transmembrane (TM) domains 3, 4, 5, and 6. The Phe (F-NH(2)) interacted favorably with Tyr110 (TM3), while the Arg makes salt bridges to Asp161 (TM4) and Asp179 (TM5). We predicted that the Met extends from the binding site, but the terminal Phe residue sticks back into an aromatic/hydrophobic site flanked by Tyr237, Leu238, Leu240, and Tyr256 (TM6), and Trp162 (TM4). We carried out subsequent mutagenesis experiments followed by intracellular calcium-release assays that demonstrated the dramatic decrease in activity for the Tyr110Ala, Asp161Ala, and Asp179Ala substitutions, which was predicted by our model. These experiments provide strong evidence that our predicted G protein-coupled receptor (GPCR) structure is sufficiently accurate to identify binding sites for selective ligands. Similar studies were made with the mMrgA1 receptor, which did not bind the R-F-NH(2) dipeptide; we explain this to be due to the increased hydrophobic character of the binding pocket in mMrgA1.


Subject(s)
FMRFamide/chemistry , FMRFamide/metabolism , Receptors, G-Protein-Coupled/metabolism , Animals , Binding Sites , Biotinylation , Calcium/metabolism , Computer Simulation , Immunoprecipitation , Ligands , Membrane Transport Modulators/chemistry , Membrane Transport Modulators/metabolism , Mice , Models, Molecular , Mutagenesis, Site-Directed , Point Mutation/genetics , Protein Conformation , Receptors, G-Protein-Coupled/genetics
7.
Neuron ; 52(4): 691-703, 2006 Nov 22.
Article in English | MEDLINE | ID: mdl-17114052

ABSTRACT

Phospholipase Cbeta (PLCbeta) isozymes represent a family of molecules that link G protein-coupled receptors (GPCRs) to an intracellular signaling network. Here, we investigated the function of PLCbeta isozymes in sensory neurons by using mutant mice deficient for specific PLCbeta family members. Expression analysis indicated that PLCbeta3, one of the four isoforms, is predominantly expressed in a subpopulation of C-fiber nociceptors. A subset of these neurons expressed the histamine H1 receptor. Ca(2+) imaging studies revealed that PLCbeta3 specifically mediates histamine-induced calcium responses through the histamine H1 receptor in cultured sensory neurons. In line with this, we found that PLCbeta3(-/-) mice showed significant defects in scratching behavior induced by histamine; histamine-trifluoromethyl-toluidine (HTMT), a selective H1 agonist; and compound 48/80, a mast cell activator. These results demonstrate that PLCbeta3 is required to mediate "itch" sensation in response to histamine acting on the histamine H1 receptor in C-fiber nociceptive neurons.


Subject(s)
Ganglia, Spinal/metabolism , Isoenzymes/metabolism , Nerve Fibers, Unmyelinated/metabolism , Neurons, Afferent/metabolism , Nociceptors/metabolism , Receptors, Histamine H1/metabolism , Type C Phospholipases/metabolism , Animals , Calcium Signaling/drug effects , Calcium Signaling/physiology , Cells, Cultured , Disease Models, Animal , Female , Ganglia, Spinal/drug effects , Histamine/metabolism , Histamine/pharmacology , Histamine Agonists/pharmacology , Isoenzymes/genetics , Male , Mast Cells/drug effects , Mast Cells/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Fibers, Unmyelinated/drug effects , Neurons, Afferent/drug effects , Nociceptors/drug effects , Phospholipase C beta , Pruritus/chemically induced , Pruritus/metabolism , Pruritus/physiopathology , Rats , Rats, Wistar , Receptors, Histamine H1/drug effects , Reflex/drug effects , Reflex/physiology , Sciatic Neuropathy/metabolism , Sciatic Neuropathy/physiopathology , Signal Transduction/drug effects , Signal Transduction/physiology , Type C Phospholipases/genetics
8.
J Biol Chem ; 278(40): 38813-20, 2003 Oct 03.
Article in English | MEDLINE | ID: mdl-12796497

ABSTRACT

We previously reported that exogenously added human group V phospholipase A2 (hVPLA2) could elicit leukotriene B4 biosynthesis in human neutrophils through the activation of group IVA phospholipase A2 (cPLA2) (Kim, Y. J., Kim, K. P., Han, S. K., Munoz, N. M., Zhu, X., Sano, H., Leff, A. R., and Cho, W. (2002) J. Biol. Chem. 277, 36479-36488). In this study, we determined the functional significance and mechanism of the exogenous hVPLA2-induced arachidonic acid (AA) release and leukotriene C4 (LTC4) synthesis in isolated human peripheral blood eosinophils. As low a concentration as 10 nm exogenous hVPLA2 was able to elicit the significant release of AA and LTC4 from unstimulated eosinophils, which depended on its ability to act on phosphatidylcholine membranes. hVPLA2 also augmented the release of AA and LTC4 from eosinophils activated with formyl-Met-Leu-Phe + cytochalasin B. A cellular fluorescent PLA2 assay showed that hVPLA2 had a lipolytic action first on the outer plasma membrane and then on the perinuclear region. hVPLA2 also caused the translocation of 5-lipoxygenase from the cytosol to the nuclear membrane and a 2-fold increase in 5-lipoxygenase activity. However, hVPLA2 induced neither the increase in intracellular calcium concentration nor cPLA2 phosphorylation; consequently, cPLA2 activity was not affected by hVPLA2. Pharmacological inhibition of cPLA2 and the hVPLA2-induced activation of eosinophils derived from the cPLA2-deficient mouse corroborated that hVPLA2 mediates the release of AA and leukotriene in a cPLA2-independent manner. As such, this study represents a unique example in which a secretory phospholipase induces the eicosanoid formation in inflammatory cells, completely independent of cPLA2 activation.


Subject(s)
Cysteine/chemistry , Eosinophils/metabolism , Leukotrienes/biosynthesis , Phospholipases A/metabolism , Phospholipases A/physiology , Animals , Arachidonate 5-Lipoxygenase/metabolism , Arachidonic Acid/metabolism , Blotting, Western , Bone Marrow Cells , Calcium/metabolism , Cell Membrane/metabolism , Cells, Cultured , Cytochalasin B/metabolism , Dose-Response Relationship, Drug , Enzyme Activation , Enzyme-Linked Immunosorbent Assay , Group IV Phospholipases A2 , Group V Phospholipases A2 , Humans , Hydrolysis , Immunohistochemistry , Leukotriene C4/metabolism , Mice , Microscopy, Fluorescence , Neutrophils/metabolism , Phosphatidylcholines/metabolism , Phospholipases A2 , Phosphorylation , Protein Isoforms , Time Factors
9.
J Cell Physiol ; 194(2): 127-38, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12494451

ABSTRACT

Previously, we demonstrated that the gastrin releasing peptide (GRP) induces cyclooxygenase-2 (COX-2) expression through a Rho-dependent, protein kinase C (PKC)-independent signaling pathway in fibroblasts (Slice et al., 1999, J Biol Chem 274:27562-27566). However, the specific role of heterotrimeric guanine nucleotide binding regulatory proteins (G-proteins) that are coupled to the GRP receptor in Rho-dependent COX-2 expression has not been elucidated. In this report, we utilize embryonic fibroblasts from transgenic mice containing double gene knock-outs (DKO) for Galpha(q/11) and Galpha(12/13) to demonstrate that COX-2 promoter activation by GRP requires Galpha(q). Furthermore, we show that GRP-dependent COX-2 gene expression, as assessed by a COX-2 reporter luciferase assay, was induced in cells lacking Galpha(12/13) but was blocked in cells that did not express Galpha(q/11). GRP-dependent COX-2 promoter induction in Galpha(q/11) deficient cells was rescued by expression of wild type Galpha(q) but blocked by inhibition of calcium signaling in calcium-free media or in cells treated with 2-aminoethoxydiphenylborate (2-APB). Co-stimulation of transfected Galpha(q/11) deficient cells with GRP and thapsigargin (TG) induced the COX-2 promoter. Activation of endogenous Rho by expression of Onco-lbc or expression of Rho A Q63L resulted in COX-2 promoter activation in Galpha(q/11) deficient cells. Inhibition of Rho by Clostridium botulinum C3 toxin blocked COX-2 promoter induction. Expression of Galpha(q) Q209L in the well-characterized fibroblast cell line, NIH3T3, induced the COX-2 promoter which was blocked by expression of C3 toxin. These results demonstrate that calcium signaling mediated by Galpha(q) and Rho play critical roles in GRP-dependent COX-2 expression in fibroblasts.


Subject(s)
Eye Proteins , Fibroblasts/physiology , Heterotrimeric GTP-Binding Proteins/physiology , Isoenzymes/genetics , Promoter Regions, Genetic/physiology , Prostaglandin-Endoperoxide Synthases/genetics , Rho Factor/physiology , Signal Transduction/physiology , Transcriptional Activation/physiology , Activating Transcription Factors , Animals , Blood Proteins/physiology , Calcium Signaling/physiology , Cyclooxygenase 2 , G-Protein-Coupled Receptor Kinase 1 , GTP-Binding Protein alpha Subunits, Gi-Go/physiology , GTP-Binding Protein alpha Subunits, Gq-G11 , GTP-Binding Proteins/genetics , Gastrin-Releasing Peptide/physiology , Heterotrimeric GTP-Binding Proteins/genetics , Mice , Mice, Knockout , Protein Isoforms/metabolism , Protein Kinase C/physiology , Protein Kinases/deficiency , Protein Kinases/genetics , RNA, Messenger/metabolism , Transcription Factors/physiology
10.
Proc Natl Acad Sci U S A ; 99(23): 14740-5, 2002 Nov 12.
Article in English | MEDLINE | ID: mdl-12397184

ABSTRACT

MrgA1 and MrgC11 belong to a recently identified family of orphan G-protein coupled receptors, called mrgs (mas-related genes). They are only expressed in a specific subset of sensory neurons that are known to detect painful stimuli. However, the precise physiological function of Mrg receptors and their underlying mechanisms of signal transduction are not known. We therefore have screened a series of neuropeptides against human embryonic kidney (HEK) 293 cells that stably express either MrgA1 or MrgC11 to identify ligands and/or agonists. MrgA1- or MrgC11-specific agonists stimulated dose-dependent increases in intracellular free Ca(2+) in a pertussis toxin-insensitive manner, but failed to alter basal or forskolin-stimulated levels of intracellular cAMP. Furthermore, studies using embryonic fibroblasts derived from various Galpha protein knockout mice demonstrated that both the MrgA1 and MrgC11 receptors are coupled to the Galpha(q/11) signaling pathway. Screening of neuropeptides identified surrogate agonists, most of these peptides included a common C-terminal -RF(Y)G or -RF(Y) amide motif. Structure-function studies suggest that endogenous ligands of Mrg receptors are likely to be RF(Y)G and/or RF(Y) amide-related peptides and that postprocessing of these peptides may serve to determine Mrg receptor-ligand specificity. The differences in ligand specificity also suggest functional diversity amongst the Mrg receptors.


Subject(s)
GTP-Binding Proteins/metabolism , Heterotrimeric GTP-Binding Proteins/physiology , Receptors, Cell Surface/physiology , Receptors, G-Protein-Coupled , Amino Acid Sequence , Animals , Calcium Signaling/physiology , Cell Line , Cyclic AMP/metabolism , Fibroblasts/cytology , Fibroblasts/physiology , GTP-Binding Protein alpha Subunits, Gq-G11 , Humans , Mice , Mice, Knockout , Molecular Sequence Data , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Signal Transduction , Transfection
11.
J Biol Chem ; 277(39): 36479-88, 2002 Sep 27.
Article in English | MEDLINE | ID: mdl-12124392

ABSTRACT

We reported previously that exogenously added human group V phospholipase A(2) (hVPLA(2)) could elicit leukotriene B(4) (LTB(4)) biosynthesis in human neutrophils (Han, S. K., Kim, K. P., Koduri, R., Bittova, L., Munoz, N. M., Leff, A. R., Wilton, D. C., Gelb, M. H., and Cho, W. (1999) J. Biol. Chem. 274, 11881-11888). To determine the mechanism of the hVPLA(2)-induced LTB(4) biosynthesis in neutrophils, we thoroughly examined the effects of hVPLA(2) and their lipid products on the activity of group IVA cytosolic PLA(2) (cPLA(2)) and LTB(4) biosynthesis under different conditions. As low as 1 nm exogenous hVPLA(2) was able to induce the release of arachidonic acid (AA) and LTB(4). Typically, AA and LTB(4) were released in two phases, which were synchronized with a rise in intracellular calcium concentration ([Ca(2+)](i)) near the perinuclear region and cPLA(2) phosphorylation. A cellular PLA(2) assay showed that hVPLA(2) acted primarily on the outer plasma membrane, liberating fatty acids and lysophosphatidylcholine (lyso-PC), whereas cPLA(2) acted on the perinuclear membrane. Lyso-PC and polyunsaturated fatty acids including AA activated cPLA(2) and 5-lipoxygenase by increasing [Ca(2+)](i) and inducing cPLA(2) phosphorylation, which then led to LTB(4) biosynthesis. The delayed phase was triggered by the binding of secreted LTB(4) to the cell surface LTB(4) receptor, which resulted in a rise in [Ca(2+)](i) and cPLA(2) phosphorylation through the activation of mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2. These results indicate that a main role of exogenous hVPLA(2) in neutrophil activation and LTB(4) biosynthesis is to activate cPLA(2) and 5-lipoxygenase primarily by liberating from the outer plasma membrane lyso-PC that induces [Ca(2+)](i) increase and cPLA(2) phosphorylation and that hVPLA(2)-induced LTB(4) production is augmented by the positive feedback activation of cPLA(2) by LTB(4).


Subject(s)
Leukotrienes/biosynthesis , Neutrophils/enzymology , Phospholipases A/metabolism , Calcium/metabolism , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Enzyme Activation , Group IV Phospholipases A2 , Group V Phospholipases A2 , Humans , Hydrolysis , Immunoblotting , Lysophosphatidylcholines/metabolism , Microscopy, Confocal , Neutrophils/metabolism , Phospholipases A2 , Recombinant Proteins/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...